KCM
JAZZ icon

Kennedy Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kennedy Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.17M Buy
29,773
+12,170
+69% +$2.67M 0.13% 260
2026
Q1 		$3.33M Buy
17,603
+375
+2% +$65.5K 0.07% 359
2025
Q4 		$2.93M Sell
17,228
-195
-1% -$29.9K 0.06% 384
2025
Q3 		$2.3M Buy
17,423
+7,056
+68% +$846K 0.05% 428
2025
Q2 		$1.1M Buy
+10,367
New +$1.13M 0.03% 501

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Kennedy Capital Management's JAZZ Position: Q2 2026 in Review

Kennedy Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 69% in Q2 2026, buying an estimated $2.67M and bringing the position to 29,773 shares worth $7.17M. The position accounts for 0.13% of the portfolio, ranked #260.

Kennedy Capital Management first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Kennedy Capital Management held 29,773 shares of Jazz Pharmaceuticals worth $7.17M as of Q2 2026.
  • Kennedy Capital Management bought 12,170 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.67M.
  • Jazz Pharmaceuticals made up 0.13% of Kennedy Capital Management's portfolio in Q2 2026, its #260 holding.
  • Kennedy Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.